Graft-Versus-Host Disease Prophylaxis with Posttransplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis

被引：0
|
作者：
Morozova, Elena V.
Moiseev, Ivan S.
Barabanshikova, Maria V.
Darskaya, Elena I.
Bondarenko, Sergey N.
Zubarovskaya, Ludmila S.
Baykov, Vadim
Alyanski, Alexandr L.
Barkhatov, Ildar M.
Zander, Axel R.
Afanasyev, Boris V.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4492
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Ruxolitinib for the treatment of acute graft-versus-host disease: a retrospective analysis
    Denk, Alexander
    Edinger, Matthias
    Weber, Daniela
    Holler, Ernst
    Fante, Matthias
    Meedt, Elisabeth
    Gunes, Sibel
    Poeck, Hendrik
    Mittermaier, Cornelia
    Herr, Wolfgang
    Wolff, Daniel
    ANNALS OF HEMATOLOGY, 2024, 103 (08) : 3071 - 3081
  • [32] Ruxolitinib for steroid-refractory acute graft-versus-host disease
    Toama, Wael
    Fiala, Mark
    Pusic, Iskra
    Westervelt, Peter
    Dipersio, John F.
    Schroeder, Mark
    TRANSPLANT INTERNATIONAL, 2020, 33 (02) : 244 - 246
  • [33] Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
    Zeiser, Robert
    Polverelli, Nicola
    Ram, Ron
    Hashmi, Shahrukh K.
    Chakraverty, Ronjon
    Middeke, Jan Moritz
    Musso, Maurizio
    Giebel, Sebastian
    Uzay, Ant
    Langmuir, Peter
    Hollaender, Norbert
    Gowda, Maanasa
    Stefanelli, Tommaso
    Lee, Stephanie J.
    Teshima, Takanori
    Locatelli, Franco
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (03): : 228 - 238
  • [34] Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease
    Khoury, Hanna Jean
    Langston, Amelia A.
    Kota, Vamsi K.
    Wilkinson, Jennifer A.
    Pusic, Iskra
    Jillella, Anand
    Bauer, Stephanie
    Kim, Audrey S.
    Roberts, Danielle
    Al-Kadhimi, Zaid
    Bodo, Imre
    Winton, Elliott
    Arellano, Martha
    DiPersio, John F.
    BONE MARROW TRANSPLANTATION, 2018, 53 (07) : 826 - 831
  • [35] Ruxolitinib treatment for steroid-refractory graft-versus-host disease
    Park, Han-Seung
    Lee, Je-Hwan
    Lee, Jung-Hee
    Choi, Eun-Ji
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Lee, Kyoo-Hyung
    BONE MARROW TRANSPLANTATION, 2019, 54 : 323 - 324
  • [36] Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease
    Hanna Jean Khoury
    Amelia A. Langston
    Vamsi K. Kota
    Jennifer A. Wilkinson
    Iskra Pusic
    Anand Jillella
    Stephanie Bauer
    Audrey S Kim
    Danielle Roberts
    Zaid Al-Kadhimi
    Imre Bodo
    Elliott Winton
    Martha Arellano
    John F. DiPersio
    Bone Marrow Transplantation, 2018, 53 : 826 - 831
  • [37] Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
    Zeiser, Robert
    von Bubnoff, Nikolas
    Butler, Jason
    Mohty, Mohamad
    Niederwieser, Dietger
    Or, Reuven
    Szer, Jeff
    Wagner, Eva M.
    Zuckerman, Tsila
    Mahuzier, Bruyere
    Xu, Judith
    Wilke, Celine
    Gandhi, Kunal K.
    Socie, Gerard
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (19): : 1800 - 1810
  • [38] Publication of recent Data on Ruxolitinib in acute Graft-versus-Host Disease
    不详
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2020, 47 (03) : 276 - 276
  • [39] Sirolimus-Containing Graft-Versus-Host Disease Prophylaxis in Patients With Lymphoma
    Mehta, Jayesh
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) : E138 - E138
  • [40] Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease
    Kumar, S
    Chen, MG
    Gastineau, DA
    Gertz, MA
    Inwards, DJ
    Lacy, MQ
    Tefferi, A
    Harmsen, WS
    Litzow, MR
    BONE MARROW TRANSPLANTATION, 2001, 27 (11) : 1133 - 1140
12345